Recommendations for commissioning medicines and technologies where there is no NICE or national guidance, and resources to support the implementation of NICE Technology Appraisals.
Cannabis: Unlicensed cannabis-based medicines - Statement on prescribing in primary care.pdf
Dibotermin alfa for the management of acute tibial fractures in adults v3.pdf
EXOGEN® ultrasound bone healing system.zip
Immune Check Point Inhibitor Induced Colitis.pdf
Insulin degludec (Tresiba®).pdf
Insulin glargine 300 units_ml - Toujeo®.pdf
Iron chelators for iron overload in Myelodysplastic syndrome.pdf
IQoro neuromuscular training device.pdf
Liothyronine oral (all indications).pdf
Naltrexone and bupropion (Mysimba®) for obesity.pdf
Novel nicotine containing devices.pdf
Oxygen in cluster headaches.pdf
PCSK9 inhibitors Alirocumab and Evolocumab.zip
Psoriasis - biologic treatment of localised severe psoriasis.zip
Rifaximin for the management of chronic diarrhoea associated with gastro-intestinal disorders.pdf
Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy in adults.zip
Solriamfetol in the management of narcolepsy with cataplexy in adults aged 19 and older.zip
Thuasne Action Reliever Knee brace.pdf
Tolvaptan (Samsca®) for hyponatraemia secondary to SIADH.pdf
